Netflix's chairman, Reed Hastings, reportedly divested $1.1 billion worth of his shares at the streaming company and handed them to an unnamed group as gifts. As indicated in a recent regulatory filing, the executive chair who co-founded the company gave two million shares of his holdings at Netflix.
The shares' current value is more than $1.1 billion, and he gave them all to an entity that was not publicly disclosed but was named in the filing. According to CNBC, Hastings's total net worth today is $6.6 billion based on the Bloomberg Billionaires Index.
Charity Gifts: Hasting's Habit of Giving
The Netflix chair is giving away around 40% of his direct holdings for charity. Hastings is not new in sharing his wealth as he already had several philanthropic activities on his record. Before this new donation announcement, the most recent one was pledged in 2020. At that time, he said he would give $120 million to two Black colleges and universities and the United Negro College Fund.
Then again, the vice president of VerityData, Ben Silverman, told CNBC that Hasting's latest gift to an undisclosed entity had not yet been classified. "We do not know what it could be, whether it is a charity or multiple charities. There is always a possibility that they are shifting the stock somewhere else, for example to a trust where they do not have control or are not a beneficiary," he said.
Uncovering the Recipient of the Huge "Gift"
Meanwhile, in a new update, the beneficiary of the "gift" has been named. It was revealed that Hastings had given $1.1 billion in Netflix shares to Silicon Valley Community Foundation.
Bloomberg reported that Netflix's spokesperson confirmed that this group received the grant. The funds are meant for affordable housing, disaster relief, early childhood development, and other causes.


SoftBank Shares Surge as OpenAI IPO Buzz and SB Energy Filing Boost AI Optimism
Google, Blackstone Launch $5B AI Cloud Venture to Challenge Nvidia and CoreWeave
OpenAI Eyes IPO Filing as Early as This Week Amid Rising AI Competition
JPMorgan Sees Large-Cap Biotech Stocks Entering New Growth Phase in 2026
Sonova Beats Profit Forecasts Despite Cochlear Implant Weakness
Intuit Raises Full-Year Forecast After Strong Q3 Earnings Despite Stock Drop
SpaceX IPO Nears as Goldman Sachs Set to Lead Historic $75 Billion Offering
Anthropic to Brief Financial Stability Board on AI-Driven Cyber Risks
Samsung Shares Surge After Strike Deal Eases Labor Tensions
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
Thyssenkrupp to Shut Down Indiana Automotive Plant by March 2026
Japan Airlines Signs 10-Year Boeing 787 Maintenance Deal With GE Aerospace
OpenAI Wins Elon Musk Lawsuit as Jury Rejects Claims Over AI Mission
TrumpRx Expands Discount Drug Access With 600 Generic Medications 



